USPTO serial 50092146
KREAMEDICA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with KREAMEDICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Pointe-Claire, QC, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas P. Gulick
Thomas P. Gulick McNees Wallace & Nurick LLC100 Pine StreetHarrisburg, PA 17101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting services in the fields of biotechnology and pharmaceuticals; business project management services for biotechnology and pharmaceutical companies; business management of outsourcing; business administration of relationships with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs); business development services, namely, providing qualified business sales leads to contract research organizations and contract development and manufacturing organizations | ACTIVE | — |
| 036 | Capital investment services; venture capital financing services; providing financing to biotechnology companies | ACTIVE | — |
| 042 | Scientific research consulting in the fields of biotechnology and pharmaceutical development; consulting services relating to preclinical and clinical drug development strategies; technical coordination of chemistry, manufacturing, and controls (CMC) workflows for pharmaceutical products; research and development project management in the field of new pharmaceutical products; regulatory consulting services relating to the scientific development of pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 4, 2026 | NWAP | NEW APPLICATION ENTERED | — |
| Sep 4, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |